Tod Smeal

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Metastatic Colorectal Cancer

Prognostic Factors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)